The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis - Top-Institutions - MDSpire

The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis

  • By

  • Gianmaria Salvio

  • Alessandro Ciarloni

  • Nairus Aboud

  • Nicola Ambo

  • Monia Bordoni

  • Beatrice Lucchetti

  • Marianna Martino

  • Michele Perrone

  • Matteo Gasparroni

  • Giancarlo Balercia

  • Giorgio Arnaldi

  • December 23, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Neurosurgery
    • Metabolic Disorders

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Neurosurgery
    • Cardiovascular Medicine

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrinology
    • Neurosurgery
    • Cardiology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Neurosurgery
    • Metabolic Research

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Neurosurgery
    • Cardiovascular Medicine

Original Source(s)

The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysis

  • by Gianmaria Salvio, Alessandro Ciarloni, Nairus Aboud, Nicola Ambo, Monia Bordoni, Beatrice Lucchetti, Marianna Martino, Michele Perrone, Matteo Gasparroni, Giancarlo Balercia, Giorgio Arnaldi

  • December 23, 2025

Related Content

The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease

Intensive blood pressure control in type 2 diabetes: a meta-analysis of randomized controlled trials

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.